Umoja Biopharma

Biotechnology

Develops approaches that generate cancer-fighting immune cells inside a patient’s body.

Source
Reported stage
Series C
Local presence
Seattle

$100M Series C announced January 14, 2025.

Research snapshot: 2026-11-01. Funding may have changed since the linked report.